BC
BioCardia, Inc.
BCDA · NASDAQ
$1.04 -1.89% (-$0.02)
1M -3.70%
Market Cap $15.8M
P/E Ratio -
Div. Yield -
ROE 569.36%
Analiza
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Piotroski F-Score Weak
1/9Valuation
27 /100
Expensive P/B 5.84x
P/E N/A
EV/FFO N/A
Growth
0 /100
Declining Book val. growth 43.23%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 246.91%
Asset turnover 0.00x
ROE 569.36%
Debt
100 /100
Low Debt/Equity 0.11x
Current ratio 2.09x
Int. coverage N/A
Stability
60 /100
Moderate Beta 0.49x
Profitable years 0
Rev. volatility 17.92%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o BCDA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Peter A. Altman
Employees
17
Headquarters
Sunnyvale
Prihajajoči dogodki
11 NOV.
Earnings
Upcoming earnings report